Human Solute carrier family 22 member 5 (SLC22A5) activation kit by CRISPRa

CAT#: GA104502

SLC22A5 CRISPRa kit - CRISPR gene activation of human solute carrier family 22 member 5

  See Other Versions


Find the corresponding CRISPRi Inhibitor Kit

USD 1,290.00

2 Weeks*

Size
    • 1 kit

Product Images

Frequently bought together (2)
Anti-SLC22A5 Rabbit Polyclonal Antibody
    • 100 ul

USD 345.00


qSTAR qPCR primer pairs against Homo sapiens gene SLC22A5
    • 200 reactions

USD 120.00

Other products for "SLC22A5"

Specifications

Product Data
Format 3gRNAs, 1 scramble ctrl and 1 enhancer vector
Symbol SLC22A5
Locus ID 6584
Kit Components

GA104502G1, Solute carrier family 22 member 5 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA104502G2, Solute carrier family 22 member 5 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA104502G3, Solute carrier family 22 member 5 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer The kit is designed based on the best knowledge of CRISPa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_003060, NM_001308122
Synonyms CDSP; OCTN2
Summary 'Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]'

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.